期刊
PROTEIN ENGINEERING DESIGN & SELECTION
卷 19, 期 12, 页码 525-535出版社
OXFORD UNIV PRESS
DOI: 10.1093/protein/gzl040
关键词
Cyanovirin-N; high-mannose oligosaccharides; mutant design; viral env glycoprotein; virucidal agent
The HIV-inactivating protein Cyanovirin-N (CV-N) is a cyanobacterial lectin that exhibits potent antiviral activity at nanomolar concentrations by interacting with high-mannose carbohydrates on viral glycoproteins. To date there is no molecular explanation for this potent virucidal activity, given the experimentally measured micromolar affinities for small sugars and the problems encountered with aggregation and precipitation of high-mannose/CV-N complexes. Here, we present results for two CV-N variants, CV-N-mutDA and CV-N-mutDB, compare their binding properties with monomeric [P51G]CV-N (a stabilized version of wtCV-N) and test their in vitro activities. The mutations in CV-N-mutDA and CV-N-mutDB comprise changes in amino acids that alter the trimannose specificity of domain A(M) and abolish the sugar binding site on domain B-M, respectively. We demonstrate that carbohydrate binding via domain B-M is essential for antiviral activity, whereas alterations in sugar binding specificity on domain A(M) have little effect on envelope glycoprotein recognition and antiviral activity. Changes in A(M), however, affect the cross-linking activity of CV-N. Our findings augment and clarify the existing models of CV-N binding to N-linked glycans on viral glycoproteins, and demonstrate that the nanomolar antiviral potency of CV-N is related to the constricted and spatially crowded arrangement of the mannoses in the glycan clusters on viral glycoproteins and not due to CV-N induced virus particle agglutination, making CV-N a true viral entry inhibitor.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据